Gene-centric association signals for haemostasis and thrombosis traits identified with the HumanCVD BeadChip

Thrombosis and Haemostasis

Volumn 110, Issue 5, 2013, Pages 995-1003

  Gaunt, Tom R ^a   Zabaneh, Delilah ^b   Shah, Sonia ^b   Guyatt, Anna ^a   Ladroue, Christophe ^a   Kumari, Meena ^b   Drenos, Fotios ^b   Shah, Tina ^b   Talmud, Philippa J ^b   Casas, Juan Pablo ^b,c   Lowe, Gordon ^d   Rumley, Ann ^d   Lawlor, Debbie A ^a   Kivimaki, Mika ^b   Whittaker, John ^c,e   Hingorani, Aroon D ^b   Humphries, Steve E ^b   Day, Ian N ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Clotting factors; Genetic association; Haemostasis; HumanCVD; Thrombosis

Indexed keywords

APOLIPOPROTEIN A5; BLOOD CLOTTING FACTOR 7; COLONY STIMULATING FACTOR 1; FIBRINOGEN; G PROTEIN COUPLED RECEPTOR KINASE 5; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; FEMALE; FLOW CYTOMETRY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); NULL HYPOTHESIS; PHENOTYPE; PHENOTYPIC VARIATION; PLASMA VISCOSITY; PLEIOTROPY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE COUNT; THROMBOSIS; VISCOMETER;

CLOTTING FACTORS; GENETIC ASSOCIATION; HAEMOSTASIS; HUMANCVD; THROMBOSIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOLIPOPROTEINS A; BLOOD PLATELETS; BLOOD VISCOSITY; CARRIER PROTEINS; CELL COUNT; DNA MUTATIONAL ANALYSIS; FACTOR VII; FIBRINOGEN; G-PROTEIN-COUPLED RECEPTOR KINASE 5; GENETIC ASSOCIATION STUDIES; HEMOSTASIS; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MICROARRAY ANALYSIS; MICROSPHERES; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT, HERITABLE; THROMBOSIS;

EID: 84886991672     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-02-0087     Document Type: Article

References (42)

1. MacCallum PK, Meade TW. Haemostatic function, arterial disease and the prevention of arterial thrombosis. Baillieres Best Pract Res Clin Haematol 1999; 12: 577-599.
2. Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991; 30: 10363-10370.
3. Smith NL, Chen MH, Dehghan A, et al. Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand Factor. Circulation 2010; 121: 1382-1392.
4. Taylor KC, Lange LA, Zabaneh D, et al. A gene-centric association scan for Coagulation Factor VII levels in European and African Americans: the Candidate Gene Association Resource (CARe) Consortium. Human Molecular Genetics 2011; 20: 3525-3534.
5. Danik JS, Paré G, Chasman DI, et al. Novel Loci, Including Those Related to Crohn Disease, Psoriasis, and Inflammation, Identified in a Genome-Wide Association Study of Fibrinogen in 17 686 Women/CLINICAL PERSPECTIVE. Circulation: Cardiovascular Genetics 2009; 2: 134-141.
6. Dehghan A, Yang Q, Peters A, et al. Association of Novel Genetic Loci With Circulating Fibrinogen Levels/CLINICAL PERSPECTIVE. Circulation: Cardiovascular Genetics 2009; 2: 125-133.
7. Yang Q, Kathiresan S, Lin JP, et al. Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study. BMC Med Genet 2007; 8 (Suppl 1): S12.
8. Zemunik T, Boban M, Lauc G, et al. Genome-wide association study of biochemical traits in Korcula Island, Croatia. Croat Med J 2009; 50: 23-33.
9. Kamatani Y, Matsuda K, Okada Y, et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat Genet 2010; 42: 210-215.
10. Soranzo N, Spector TD, Mangino M, et al. A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet 2009; 41: 1182-1190.
11. Soranzo N, Rendon A, Gieger C, et al. A novel variant on chromosome 7q22. 3 associated with mean platelet volume, counts, and function. Blood 2009; 113: 3831-3837.
12. Ferreira MAR, Hottenga JJ, Warrington NM, et al. Sequence Variants in Three Loci Influence Monocyte Counts and Erythrocyte Volume. The American Journal of Human Genetics 2009; 85: 745-749.
13. Gieger C, Radhakrishnan A, Cvejic A, et al. New gene functions in megakaryopoiesis and platelet formation. Nature 2011; 480: 201-208.
14. Constantino M, Merskey C, Kudzma DJ, et al. Increased activity of vitamin K-dependent clotting factors in human hyperlipoproteinaemia-association with cholesterol and triglyceride levels. Thromb Haemost 1977; 38: 465-474.
15. Rosenson RS, Shott S, Tangney CC. Hypertriglyceridemia is associated with an elevated blood viscosity Rosenson: triglycerides and blood viscosity. Atherosclerosis 2002; 161: 433-439.
16. Keating BJ, Tischfield S, Murray SS, et al. Concept, Design and Implementation of a Cardiovascular Gene-Centric 50 K SNP Array for Large-Scale Genomic Association Studies. PLoS ONE 2008; 3: e3583.
17. Lawlor DA, Bedford C, Taylor M, et al. Aspirin use for the prevention of cardiovascular disease: the British Womens Heart and Health Study. Br J Gen Pract 2001; 51: 743-745.
18. Lawlor DL, Ebrahim SE, Davey Smith GDS. The association between components of adult height and Type II diabetes and insulin resistance: British Women's Heart and Health Study. Diabetologia 2002; 45: 1097-1106.
19. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 1988; 16: 1215.
20. Marmot MG, Stansfeld S, Patel C, North F, Head J, White I, et al. Health inequalities among British civil servants: the Whitehall II study. Lancet 1991; 337: 1387-1393.
21. Marmot M, Brunner E. Cohort Profile: The Whitehall II study. Int J Epidemiol 2005; 34: 251-256.
22. Talmud PJ, Drenos F, Shah S, et al. Gene-centric Association Signals for Lipids and Apolipoproteins Identified via the HumanCVD BeadChip. Am J Human Genet 2009; 85: 628-642.
23. Purcell S, Neale B, Todd-Brown K, et al. PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses. Am J Human Genet 2007; 81: 559-575.
24. Undas A, Brummel-Ziedins KE, et al. Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions. Blood 2007; 109: 2285-2292.
25. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010; 26: 2190-2191.
26. Akaike H. New Look at Statistical-Model Identification. Ieee Transactions on Automatic Control 1974; AC19: 716-723.
27. Hindorff LA, Sethupathy P, Junkins HA, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009; 106: 9362-9367.
28. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010; 466: 707-713.
29. Arraes SM, Freitas MS, da Silva SV, et al. Impaired neutrophil chemotaxis in sepsis associates with GRK expression and inhibition of actin assembly and tyrosine phosphorylation. Blood 2006; 108: 2906-2913.
30. Saxena R, Hivert MF, Langenberg C, et al. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet 2010; 42: 142-148.
31. Chambers JC, Zhang W, Sehmi J, et al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet 2011; 43: 1131-1138.
32. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT LUaNIoBR, Saxena R, et al. Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels. Science 2007; 316: 1331-1336.
33. Kathiresan S, Melander O, Guiducci C, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 2008; 40: 189-197.
34. Johansen CT, Wang J, Lanktree MB, et al. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet 2010; 42: 684-687.
35. Waterworth DM, Ricketts SL, Song K, et al. Genetic Variants Influencing Circulating Lipid Levels and Risk of Coronary Artery Disease. Arterioscl Thromb Vasc Biol 2010; 30: 2264-2276.
36. Pollin TI, Damcott CM, Shen H, et al. A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection. Science 2008; 322: 1702-1705.
37. Aulchenko YS, Ripatti S, Lindqvist I, et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 2008; 41: 47.
38. Kim WM, Merskey C, Deming QB, et al. Hyperlipidemia, hypercoagulability, and accelerated thrombosis: studies in congenitally hyperlipidemic rats and in rats and monkeys with induced hyperlipidemia. Blood 1976; 47: 275-286.
39. Andersen P. Hypercoagulability and reduced fibrinolysis in hyperlipidemia: relationship to the metabolic cardiovascular syndrome. J Cardiovasc Pharmacol 1992; 20 (Suppl 8): S29-S31.
40. Simpson HC, Mann JI, Meade TW, et al. Hypertriglyceridaemia and hypercoagulability. Lancet 1983; 1: 786-790.
41. Rosenson RS, Lowe GD. Effects of lipids and lipoproteins on thrombosis and rheology. Atherosclerosis 1998; 140: 271-280.
42. Tang W, Basu S, Kong X, et al. Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study. Blood 2010; 116: 5032-5036.